Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review.
Bakirtzis C, Lima M, De Lorenzo SS, Artemiadis A, Theotokis P, Kesidou E, Konstantinidou N, Sintila SA, Boziki MK, Parissis D, Ioannidis P, Karapanayiotides T, Hadjigeorgiou G, Grigoriadis N. Bakirtzis C, et al. Among authors: hadjigeorgiou g. Healthcare (Basel). 2023 Jul 25;11(15):2126. doi: 10.3390/healthcare11152126. Healthcare (Basel). 2023. PMID: 37570367 Free PMC article. Review.
Virus-mediated autoimmunity in Multiple Sclerosis.
Grigoriadis N, Hadjigeorgiou GM. Grigoriadis N, et al. J Autoimmune Dis. 2006 Feb 19;3:1. doi: 10.1186/1740-2557-3-1. J Autoimmune Dis. 2006. PMID: 16504001 Free PMC article.
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Kilidireas C, Voumvourakis K. Tsivgoulis G, et al. Among authors: hadjigeorgiou gm. PLoS One. 2015 Mar 10;10(3):e0116511. doi: 10.1371/journal.pone.0116511. eCollection 2015. PLoS One. 2015. PMID: 25756363 Free PMC article. Review.
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Dardiotis E, Kilidireas C, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: hadjigeorgiou gm. Ther Adv Neurol Disord. 2015 Sep;8(5):193-202. doi: 10.1177/1756285615600381. Ther Adv Neurol Disord. 2015. PMID: 26557896 Free PMC article.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K, Dardiotis E; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: hadjigeorgiou gm. PLoS One. 2015 Dec 7;10(12):e0144538. doi: 10.1371/journal.pone.0144538. eCollection 2015. PLoS One. 2015. PMID: 26642051 Free PMC article. Review.
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.
Tsivgoulis G, Katsanos AH, Mavridis D, Grigoriadis N, Dardiotis E, Heliopoulos I, Papathanasopoulos P, Karapanayiotides T, Kilidireas C, Hadjigeorgiou GM, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology). Tsivgoulis G, et al. Among authors: hadjigeorgiou gm. PLoS One. 2016 Sep 29;11(9):e0163296. doi: 10.1371/journal.pone.0163296. eCollection 2016. PLoS One. 2016. PMID: 27684943 Free PMC article.
Gene variants of adhesion molecules act as modifiers of disease severity in MS.
Dardiotis E, Panayiotou E, Provatas A, Christodoulou K, Hadjisavvas A, Antoniades A, Lourbopoulos A, Pantzaris M, Grigoriadis N, Hadjigeorgiou GM, Kyriakides T. Dardiotis E, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Apr 24;4(4):e350. doi: 10.1212/NXI.0000000000000350. eCollection 2017 Jul. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28473999 Free PMC article.
Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis.
Tsivgoulis G, Katsanos AH, Voumvourakis K, Hadjigeorgiou GM, Heliopoulos I, Karapanayiotides T, Papathanasopoulos P, Kilidireas C, Grigoriadis N. Tsivgoulis G, et al. Among authors: hadjigeorgiou gm. Mult Scler Relat Disord. 2018 Apr;21:117-119. doi: 10.1016/j.msard.2018.03.010. Epub 2018 Mar 15. Mult Scler Relat Disord. 2018. PMID: 29724375 No abstract available.
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.
Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N. Bakirtzis C, et al. Among authors: hadjigeorgiou g. J Neurol Sci. 2018 Dec 15;395:106-112. doi: 10.1016/j.jns.2018.10.004. Epub 2018 Oct 4. J Neurol Sci. 2018. PMID: 30308444
427 results